background
decemb
novel
coronaviru
infect
pneumonia
occur
wuhan
china
travelassoci
case
also
report
countri
number
case
increas
rapidli
laboratori
diagnosi
limit
method
collect
two
group
case
diagnos
experi
one
group
collect
sampl
enzymelink
immunosorb
assay
elisa
igg
igm
antibodi
group
collect
plasma
sampl
colloid
goldimmunochromatograph
assay
gica
result
sensit
combin
elisa
igm
elisa
igg
detect
sensit
combin
gica
igm
gica
igg
detect
method
neg
healthi
control
specif
signific
differ
sensit
elisa
gica
igm
igg
conclus
elisa
gica
specif
igm
igg
antibodi
convent
serolog
assay
simpl
fast
safe
result
use
clinic
refer
huge
clinic
diagnosi
treatment
pressur
diseas
rapidli
spread
wuhan
area
februari
confirm
case
report
china
tragic
surpass
peopl
china
lost
live
viru
case
death
hubei
provinc
wuhan
outsid
china
case
countri
death
type
pneumonia
caus
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
greatli
reliev
decemb
cluster
acut
respiratori
ill
known
novel
coronavirusinfect
pneumonia
ncip
occur
wuhan
hubei
provinc
china
novel
coronaviru
highli
infecti
diseas
ongo
outbreak
declar
global
public
health
emerg
novel
coronaviru
zoonot
origin
recent
identifi
patient
acut
respiratori
diseas
viru
genet
similar
sar
coronaviru
bat
sarslik
coronavirus
outbreak
health
care
worker
indic
humantohuman
transmiss
fullgenom
sequenc
phylogen
analysi
indic
distinct
clade
beta
coronavirus
associ
human
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
intern
committe
taxonomi
virus
ictv
announc
offici
classifi
sever
acut
respiratori
syndrom
coronaviru
diagnosi
base
clinic
histori
laboratori
chest
radiograph
find
confirm
current
reli
nucleic
acidbas
assay
nucleic
acidbas
assay
use
confirm
diagnosi
new
pneumonia
mani
patient
miss
diagnosi
verifi
two
new
reagent
kit
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
current
market
achiev
good
result
follow
report
follow
case
seri
approv
institut
ethic
board
wuhan
jinyintan
hospit
consecut
patient
confirm
admit
jinyintan
hospit
januari
januari
enrol
oral
consent
obtain
patient
jinyintan
hospit
locat
wuhan
hubei
provinc
endem
area
first
design
hospit
patient
wuhan
patient
enrol
studi
diagnos
accord
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
min
result
judg
color
test
control
line
detect
band
control
band
turn
red
sampl
record
posit
control
band
turn
red
detect
band
color
record
neg
neither
band
color
test
reagent
assum
work
throat
swab
sampl
sputum
sampl
alveolar
lavag
fluid
sampl
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
collect
extract
rna
patient
suspect
infect
collect
throat
swab
place
steril
test
tube
ml
steril
salin
sputum
sampl
ad
equal
volum
acetylcystein
shaken
room
temperatur
min
fulli
liquefi
total
rna
extract
use
nucleic
acid
extract
kit
qiaamp
viral
rna
mini
kit
brief
cell
lysat
transfer
collect
tube
follow
vortex
second
stand
room
temperatur
minut
collect
tube
centrifug
rpmmin
minut
analys
perform
use
spss
categor
variabl
express
frequenc
percentag
perform
use
chisquar
test
yate
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
tabl
tabl
qrtpcr
result
qrtpcr
test
sampl
known
patient
result
show
case
posit
sensit
overal
signific
differ
three
detect
method
p
signific
differ
sensit
elisa
igm
igg
gica
igm
igg
tabl
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
present
sampl
collect
nucleic
acid
detect
suspect
case
mostli
upper
respiratori
tract
sampl
mainli
throat
swab
collect
throat
swab
standard
easi
miss
diagnosi
collect
process
extrem
riski
medic
staff
confirm
diagnosi
play
import
role
facilit
patient
isol
treatment
assess
infecti
activ
howev
due
limit
capac
handl
epidem
current
scale
insuffici
suppli
assay
kit
portion
suspect
case
test
lead
incomplet
inaccuraci
updat
new
case
well
delay
diagnosi
fastperform
serolog
assay
acut
need
current
outbreak
studi
test
serum
sampl
confirm
patient
two
assay
kit
achiev
high
posit
rate
sensit
combin
elisa
igm
igg
detect
sensit
combin
gica
igm
igg
detect
healthi
control
neg
case
group
patient
diagnos
qrtpcr
sinc
mani
patient
undergo
treatment
gradual
recov
nucleic
acid
test
result
becom
neg
posit
rate
patient
test
worth
note
new
type
coronaviru
antibodi
kit
sever
acut
respiratori
syndrom
sar
like
coronaviru
igg
origin
infect
sar
may
also
posit
research
found
healthi
control
neg
specif
good
elisa
gica
specif
igm
igg
antibodi
convent
serolog
assay
offer
highthroughput
altern
allow
uniform
test
suspect
patient
facilit
complet
identif
infect
case
avoid
unnecessari
cross
infect
among
unselect
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
patient
use
plasma
serum
test
sampl
blood
sampl
collect
easili
greatli
reduc
risk
infect
medic
staff
complic
process
procedur
sampl
laboratori
test
remov
test
result
obtain
quickli
oper
simpl
safeti
medic
staff
protect
huge
clinic
diagnosi
treatment
pressur
greatli
reliev
although
elisa
gica
simpl
fast
safe
result
use
clinic
refer
case
confirm
still
depend
qrtpcr
analyz
epidemiolog
demograph
clinic
radiolog
featur
laboratori
data
need
increas
number
sampl
test
prove
sampl
test
confirm
signific
conclus
elisa
gica
specif
igm
igg
antibodi
convent
serolog
assay
simpl
fast
safe
diagnosi
result
use
clinic
refer
huge
clinic
diagnosi
treatment
pressur
greatli
reliev
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
tabl
compar
sensit
three
method
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
